Financial News
Articles published by Affimed N.V.
Affimed to Participate in Upcoming Investor Conferences
November 01, 2023
From Affimed N.V.
Via GlobeNewswire
Tickers
AFMD
Affimed Announces Listing Transfer to Nasdaq Capital Markets
October 04, 2023
From Affimed N.V.
Via GlobeNewswire
Tickers
AFMD
Affimed to Present at the Cantor Global Healthcare Conference 2023
September 21, 2023
From Affimed N.V.
Via GlobeNewswire
Tickers
AFMD
Affimed Reports Second Quarter 2023 Financial Results and Highlights Operational Progress
August 10, 2023
From Affimed N.V.
Via GlobeNewswire
Tickers
AFMD
Affimed to Report Second Quarter 2023 Financial Results & Corporate Update on August 10, 2023
August 03, 2023
From Affimed N.V.
Via GlobeNewswire
Tickers
AFMD
Affimed Reports First Quarter 2023 Financial Results and Highlights Operational Progress
May 23, 2023
From Affimed N.V.
Via GlobeNewswire
Tickers
AFMD
Affimed to Report First Quarter 2023 Financial Results & Corporate Update on May 23, 2023
May 16, 2023
From Affimed N.V.
Via GlobeNewswire
Tickers
AFMD
Affimed Announces Abstracts at the Annual Meeting of the European Hematology Association
May 11, 2023
From Affimed N.V.
Via GlobeNewswire
Tickers
AFMD
Affimed Announces Receipt of NASDAQ Deficiency Notice Regarding Minimum Bid Price Requirement
April 06, 2023
From Affimed N.V.
Via GlobeNewswire
Tickers
AFMD
Affimed to Report Full Year 2022 Financial Results & Corporate Update on March 23, 2023
March 16, 2023
From Affimed N.V.
Via GlobeNewswire
Tickers
AFMD
Affimed to Participate in Fireside Chat at the H.C. Wainwright Cell Therapy Virtual Conference
February 22, 2023
From Affimed N.V.
Via GlobeNewswire
Tickers
AFMD
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.